Vanguard Group’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.03M | Buy |
1,312,767
+14,318
| +1% | +$44K | ﹤0.01% | 3288 |
|
|
2025
Q1 | $2.51M | Sell |
1,298,449
-14,783
| -1% | -$28.5K | ﹤0.01% | 3419 |
|
|
2024
Q4 | $4.91M | Buy |
1,313,232
+306,525
| +30% | +$1.15M | ﹤0.01% | 3279 |
|
|
2024
Q3 | $4.92M | Sell |
1,006,707
-9,914
| -1% | -$48.5K | ﹤0.01% | 3278 |
|
|
2024
Q2 | $7.62M | Buy |
1,016,621
+752,406
| +285% | +$5.64M | ﹤0.01% | 3061 |
|
|
2024
Q1 | $6.56M | Buy |
+264,215
| New | +$6.56M | ﹤0.01% | 3182 |
|